These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19838951)

  • 1. Desmin expression in human cardiomyocytes and selected clinical and echocardiographic parameters in patients with chronic heart failure.
    Pawlak A; Gil RJ; Walczak E; Seweryniak P
    Kardiol Pol; 2009 Sep; 67(9):955-61. PubMed ID: 19838951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte desmin abnormalities - an accurate predictor of long-term survival in patients with chronic heart failure.
    Pawlak A; Gil RJ; Kasprzak J; Walczak E; Słysz A
    Kardiol Pol; 2009 Jul; 67(7):724-33. PubMed ID: 19649994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of desmin activity using immunohistochemical and immunofluorescent staining of myocardial biopsies in patients with chronic heart failure. Comparison of the two methods.
    Pawlak A; Gil RJ; Walczak E; Fidziańska A
    Kardiol Pol; 2007 Mar; 65(3):229-35; discussion 236. PubMed ID: 17436150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type of desmin expression in cardiomyocytes - a good marker of heart failure development in idiopathic dilated cardiomyopathy.
    Pawlak A; Gil RJ; Kulawik T; Pronicki M; Karkucińska-Więckowska A; Szymańska-Dębińska T; Gil K; Lagwinski N; Czarnowska E
    J Intern Med; 2012 Sep; 272(3):287-97. PubMed ID: 22292457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure.
    Di Somma S; Di Benedetto MP; Salvatore G; Agozzino L; Ferranti F; Esposito S; La Dogana P; Scarano MI; Caputo G; Cotrufo M; Santo LD; de Divitiis O
    Eur J Heart Fail; 2004 Jun; 6(4):389-98. PubMed ID: 15182762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of low desmin expression in cardiomyocytes in patients with idiopathic dilated cardiomyopathy.
    Pawlak A; Gil RJ; Grajkowska W; Nasierowska-Guttmejer AM; Rzezak J; Kulawik T
    Am J Cardiol; 2013 Feb; 111(3):393-9. PubMed ID: 23178054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural morphometric findings of cardiomyocytes in patients with impaired ventricular function--a comparative clinicopathological study.
    Wassilew K; Terziev D; Wassilew G; Fitzl G; Frölich K; Kandolf R; Fried A
    Cardiovasc Pathol; 2016; 25(1):25-32. PubMed ID: 26472277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytoskeletal, linkage and extracellular proteins in failing dog myocardium.
    Sharov VG; Kostin S; Todor A; Schaper J; Sabbah HN
    Heart Fail Rev; 2005 Dec; 10(4):297-303. PubMed ID: 16583178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Desmin as predictor of survival in patients with chronic heart failure].
    Wojnicz R
    Kardiol Pol; 2009 Jul; 67(7):734. PubMed ID: 19750605
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II. Cytoskeletal remodeling.
    Wang X; Li F; Campbell SE; Gerdes AM
    J Mol Cell Cardiol; 1999 Feb; 31(2):319-31. PubMed ID: 10093045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters.
    Kouris NT; Zacharos ID; Kontogianni DD; Goranitou GS; Sifaki MD; Grassos HE; Kalkandi EM; Babalis DK
    Eur J Heart Fail; 2005 Mar; 7(2):199-203. PubMed ID: 15701467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of additional improvement in outcome of patients receiving cardiac resynchronization therapy paced at the most delayed left ventricular region.
    Deplagne A; Lafitte S; Reuter S; Reant P; Ploux S; Mokrani B; Roudaut R; Jais P; Haissaguerre M; Clementy J; DosSantos P; Bordachar P
    Arch Cardiovasc Dis; 2009; 102(8-9):641-9. PubMed ID: 19786268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the ultrastructural and immunohistochemical analysis of cardiac biopsy in affected heart.
    Fidziańska A; Glinka-Lindner Z; Religa G; Walczak E
    Folia Neuropathol; 2010; 48(1):57-63. PubMed ID: 20383812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain.
    Logeart D; Beyne P; Cusson C; Tokmakova M; Leban M; Guiti C; Bourgoin P; Solal AC
    Am Heart J; 2001 Feb; 141(2):247-53. PubMed ID: 11174339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of ultrastructure and cytoskeleton during progression of cardiac hypertrophy to heart failure.
    Gupta A; Gupta S; Young D; Das B; McMahon J; Sen S
    Lab Invest; 2010 Apr; 90(4):520-30. PubMed ID: 20157292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure.
    Yndestad A; Landrø L; Ueland T; Dahl CP; Flo TH; Vinge LE; Espevik T; Frøland SS; Husberg C; Christensen G; Dickstein K; Kjekshus J; Øie E; Gullestad L; Aukrust P
    Eur Heart J; 2009 May; 30(10):1229-36. PubMed ID: 19329498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study).
    Ghio S; Freemantle N; Serio A; Magrini G; Scelsi L; Pasotti M; Cleland JG; Tavazzi L
    Eur J Echocardiogr; 2006 Oct; 7(5):373-8. PubMed ID: 16337208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure.
    Husberg C; Nygård S; Finsen AV; Damås JK; Frigessi A; Oie E; Waehre A; Gullestad L; Aukrust P; Yndestad A; Christensen G
    J Mol Cell Cardiol; 2008 Aug; 45(2):261-9. PubMed ID: 18585734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.